As cDC1s and cDC2s contribute to antitumor immunity in part through induction of tumor-reactive CD8 + and CD4 + T cells, respectively, further investigation into the specific contribution of these cells on T cell differentiation during tumor growth and immunotherapy is of interest [44]. The gene discussed is CD8A; the disease is neoplasm.